ESC Heart Failure (Apr 2023)

The use of MitraClip for nonobstructive hypertrophic cardiomyopathy with mixed severe mitral valve regurgitation

  • Jie Zeng,
  • Qinglan Shu,
  • Cong Lu,
  • Yi Wang

DOI
https://doi.org/10.1002/ehf2.14291
Journal volume & issue
Vol. 10, no. 2
pp. 1454 – 1460

Abstract

Read online

Abstract Reports on the treatment of nonobstructive hypertrophic cardiomyopathy (HCM) and severe mitral valve regurgitation (MR) with transcatheter edge‐to‐edge repair (TEER) are rare. Herein, we present the case of a 68‐year‐old Chinese man with nonobstructive HCM admitted to our hospital with dyspnoea [New York Heart Association (NYHA) functional Class IV]. Transthoracic echocardiography indicated severe MR in addition to asymmetric hypertrophy of the left ventricle. Despite administering maximal medical therapy for heart failure, the symptoms were not alleviated; because of the high risk of open surgery, TEER was performed for MR. After 4 months of follow‐up, the patient showed a significant improvement in symptoms. Herein, we also discuss and review the pathophysiology and treatment strategies for HCM patients with heart failure.

Keywords